NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $131,766,588 | -12.9% | 2,977,776 | -4.2% | 0.01% | -12.5% |
Q2 2023 | $151,270,072 | -0.8% | 3,108,715 | +13.2% | 0.01% | -11.1% |
Q1 2023 | $152,531,942 | -46.9% | 2,747,338 | -61.5% | 0.01% | +12.5% |
Q4 2022 | $286,995,530 | +133.3% | 7,144,524 | +154.5% | 0.01% | 0.0% |
Q3 2022 | $123,022,000 | +1.8% | 2,807,450 | -17.7% | 0.01% | +14.3% |
Q2 2022 | $120,828,000 | +4.9% | 3,409,372 | +20.4% | 0.01% | +16.7% |
Q1 2022 | $115,217,000 | -32.6% | 2,832,266 | +54.8% | 0.01% | -25.0% |
Q4 2021 | $170,887,000 | -5.6% | 1,829,822 | +12.6% | 0.01% | -20.0% |
Q3 2021 | $181,112,000 | +4.0% | 1,625,201 | +5.9% | 0.01% | +11.1% |
Q2 2021 | $174,153,000 | -10.2% | 1,533,985 | -19.7% | 0.01% | -18.2% |
Q1 2021 | $193,865,000 | -8.0% | 1,909,243 | -9.8% | 0.01% | -15.4% |
Q4 2020 | $210,691,000 | +32.7% | 2,117,069 | -3.7% | 0.01% | +18.2% |
Q3 2020 | $158,781,000 | +17.6% | 2,197,962 | -18.8% | 0.01% | +10.0% |
Q2 2020 | $134,985,000 | +78.1% | 2,707,280 | +6.7% | 0.01% | +42.9% |
Q1 2020 | $75,798,000 | -9.7% | 2,538,454 | +1.9% | 0.01% | +16.7% |
Q4 2019 | $83,908,000 | +23.9% | 2,490,597 | +20.6% | 0.01% | +20.0% |
Q3 2019 | $67,749,000 | +24.7% | 2,065,518 | +4.8% | 0.01% | +25.0% |
Q2 2019 | $54,346,000 | +53.5% | 1,970,480 | +14.8% | 0.00% | +33.3% |
Q1 2019 | $35,399,000 | +15.6% | 1,716,724 | -21.8% | 0.00% | 0.0% |
Q4 2018 | $30,627,000 | -29.6% | 2,193,916 | +20.8% | 0.00% | 0.0% |
Q3 2018 | $43,496,000 | +304.1% | 1,816,824 | +217.8% | 0.00% | +200.0% |
Q2 2018 | $10,763,000 | +119.1% | 571,681 | +7.8% | 0.00% | – |
Q1 2018 | $4,912,000 | +4.8% | 530,175 | +1.6% | 0.00% | – |
Q4 2017 | $4,689,000 | -22.5% | 521,751 | +11.2% | 0.00% | -100.0% |
Q3 2017 | $6,047,000 | +24.0% | 469,319 | +4.6% | 0.00% | – |
Q2 2017 | $4,875,000 | +36.9% | 448,708 | +11.8% | 0.00% | – |
Q1 2017 | $3,561,000 | -21.9% | 401,303 | +3.0% | 0.00% | – |
Q4 2016 | $4,561,000 | +8.5% | 389,498 | +2.9% | 0.00% | – |
Q3 2016 | $4,204,000 | -4.0% | 378,431 | +4.3% | 0.00% | – |
Q2 2016 | $4,377,000 | +277.3% | 362,889 | +197.9% | 0.00% | – |
Q1 2016 | $1,160,000 | -3.0% | 121,834 | +10.0% | 0.00% | – |
Q4 2015 | $1,196,000 | +22.0% | 110,756 | +22.5% | 0.00% | – |
Q3 2015 | $980,000 | – | 90,388 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |